RVTY · 8-K · 20260804PR000022
Guidance / Outlook
REVVITY, INC. · 2026-08-04 · Importance 80 · Surprise 68 · No source text
Revvity raised its full-year 2026 outlook to pro forma revenue of $2.83 billion to $2.86 billion. The company forecasts pro forma organic revenue growth of 4% to 5% and pro forma adjusted EPS of $5.30 to $5.40. The outlook is presented on a pro forma basis and excludes the China IDX business. Second-quarter pro forma organic revenue growth was 3%, with Diagnostics growing 11% organically and Life Sciences declining 3% organically.
Key facts
- Full year 2026 pro forma organic revenue growth guidance: 4-5%. source
- Full year 2026 pro forma total revenue guidance: $2.83 billion to $2.86 billion. source
- Full year 2026 pro forma adjusted earnings per share guidance: $5.30-$5.40. source
- The Company disclosed that forward-looking guidance is provided on a pro forma basis only and excludes China IDX. source
- The Company stated it is utilizing a portion of recently received tariff refunds to increase investments across the business and support future growth. source
- The Company will discuss second quarter 2026 results during a webcast on August 4, 2026 at 7:30 a.m. Eastern Time. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +3.8% | Full year 2026 pro forma organic revenue growth guidance: 4-5%. |
| revenue | positive | committed | — | Full year 2026 pro forma total revenue guidance: $2.83 billion to $2.86 billion. |
| net_income | positive | committed | — | Full year 2026 pro forma adjusted earnings per share guidance: $5.30-$5.40. |
| cash | negative | probable | — | The Company stated it is utilizing a portion of recently received tariff refunds to increase investments across the business and support… |
| assets | positive | probable | — | The Company stated it is utilizing a portion of recently received tariff refunds to increase investments across the business and support… |